Cancer Cases Among Transgender and Gender-Diverse People in England Could More Than Double Within a Decade, Study Estimates

Cancer cases among transgender and gender-diverse people in England, Digimart Global (England): A study led by Queen Mary University of London, published in eClinicalMedicine, estimates that the number of new cancer cases each year among transgender and gender-diverse people in England could more than double over the next decade.

The researchers estimate that approximately 965 new cancer cases occur annually in this population. That figure is projected to rise to around 1,739 cases in five years and 2,257 cases within 10 years.

The study is described as the first to estimate the annual number of cancer cases among transgender and gender-diverse people in England.

The researchers combined national cancer statistics, population data and existing research on the potential effects of gender-affirming healthcare. Breast cancer was estimated to be the most common cancer in this group, accounting for about 19 per cent of cases, followed by colorectal cancer at 12 per cent and lung cancer at 11 per cent.

The authors note that reliable national data on cancer incidence in this population remain limited. Current cancer registration systems do not consistently distinguish between sex characteristics and gender identity, which makes it difficult to understand cancer patterns and plan services accordingly.

The study also modelled how access to gender-affirming care, including hormone treatment and surgery, could influence future case numbers. If people were able to access the gender-affirming care they planned to receive, the projected annual number of cases in 10 years could be about 11 per cent lower, falling to 2,006. The researchers say different forms of gender-affirming care have been associated with changes in the likelihood of certain cancers, including reductions in breast cancer among trans men and prostate cancer among trans women.

Dr Alison Berner, lead author and Clinical Senior Lecturer in Medical Oncology at Queen Mary, said cancer services need to be prepared to meet patients’ needs as this population ages. Dr Chloe Pasin, co-lead author and postdoctoral researcher, said gender-affirming treatments could reduce the likelihood of some cancers while potentially increasing the risk of others, and that better data is needed.

The researchers stress that the findings are based on estimates and modelling rather than directly observed outcomes. They hope the work will help inform cancer service planning, workforce training, screening policies and more detailed data collection in healthcare.

Matilda Reeves

Matilda Reeves focuses on Australia's economy, business developments, financial markets, and technology trends. Her articles explore important industry updates and economic changes affecting Australian businesses and communities.
Copy Profile

Leave a Reply

Your email address will not be published. Required fields are marked *

Sports

Explore Digimart Global